Colgate-Palmolive India

AHold / Watchlist

COLPAL · NSE · Large Cap · FMCG Supplier

FMCG Supplier

Fetching live…

₹2,860

1D 0.3%1M 1.5%1Y 14%

Fundamental (RQ-100)

Technical (TQ-100)

Valuation

Market cap

₹78.0K Cr

Live decision ratingA+Hold

Fundamental score breakdown

87/100

Growth Quality

10.6 / 20

Rev 1Y 12.0%, 3Y CAGR 8.0%, 5Y CAGR 7.0%

Margin & Profitability

15.0 / 15

EBITDA 32.0%, PAT 22.0%

Return on Capital

20.0 / 20

ROCE 95.0%, ROE 90.0%

Cash Flow Quality

15.0 / 15

OCF/EBITDA 0.95

Leverage

10.0 / 10

ND/EBITDA -0.80

Reinvestment

5.0 / 8

Capex/Sales 2.0%

Accounting

7.0 / 7

Governance

4.0 / 5

Technical score breakdown

49/100

Trend Structure

8.0 / 20

↓ 200 · ↓ 50 · ↓ 20

Momentum

8.0 / 15

1Y 14.0%, 1M 1.5%

Volume Dynamics

8.0 / 15

Vol30 —%

Relative Strength

10.0 / 15

1Y 14.0%

MA Cluster

5.0 / 10

Extension

5.0 / 10

—% from 50DMA

Volatility

4.0 / 8

Price Action

1.0 / 7

-100.0% from 52W H

Business

What this company actually does

Oral care leader. Dominant household penetration.

Stores

—

Dark stores

—

Cities

—

Listed status

Listed

Format exposure

How direct is this play?

Primary formatFMCG Supplier

Exposure typeMeaningful

Revenue visibilityHigh

Operating leverage stageMaturity

Policy beneficiaryNone

Data confidenceMedium

Financial snapshot

Live · green dot = live, falls back to curated

Revenue

₹6.2K Cr

Rev 1Y growth

12%

Rev 3Y CAGR

EBITDA margin

32.0%

PAT margin

22.0%

ROE

90%

ROCE

95%

OCF/EBITDA

0.95

Net Debt/EBITDA

-0.8

Financial statements

Multi-year P&L, balance sheet, cash flow — scraped live from Screener.in

Fetching from Screener.in…

Loading…

Valuation

Live multiples + retail-specific (curated)

P/E

Forward P/E

EV/EBITDA

EV/Sales

11.0

P/B

38.0

FCF Yield

1.5%

Mid-range valuation. Watch incremental ROCE.

Investment thesis

AI-generated · always cite sources before acting

Bull

Best-in-class 95% ROCE with 0.95 OCF conversion. Long-runway TAM with structural tailwinds.

Base

Earnings growth of ~9% over the next 3 years assuming margins hold. Multiple compression risk if growth slows; multiple expansion possible if FMCG Supplier GMV outperforms.

Bear

Format-level risk: regulation, gig-cess, or competitive pressure compress contribution margin.

Variant perception

Consensus views Colgate-Palmolive India as a quality compounder. Our differentiated take: the cyclical pessimism in FMCG Supplier has overshot the long-term cash-flow potential.

Key monitorables

Quarterly EBITDA margin trajectory
Revenue growth vs management guidance
Capex vs store/dark-store adds
Promoter holding and ESOP dilution

Peers

Same primary format · sorted by market cap